Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurgical Innovations Regulatory News (SUN)

Share Price Information for Surgical Innovations (SUN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.50
Bid: 0.40
Ask: 0.60
Change: 0.00 (0.00%)
Spread: 0.20 (50.00%)
Open: 0.50
High: 0.50
Low: 0.50
Prev. Close: 0.50
SUN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NHS Sustainability Webinar

4 Jun 2020 07:00

RNS Number : 8936O
Surgical Innovations Group PLC
04 June 2020
 

 

Surgical Innovations Group plc

(the "Company", "SI" or the "Group")

 

NHS Sustainability Webinar

UK subsidiary and distributor Elemental Healthcare Ltd to host NHS Webinar

 

Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative technology for minimally invasive surgery, announces that its UK subsidiary and distributor Elemental Healthcare Ltd ('Elemental') is hosting an NHS Webinar on 'Sustainability and the Reduction of Plastic Waste in the Operating Theatre' taking place today, Thursday 4 June.

 

The NHS Webinar is targeted at key NHS Professionals working in Theatres, Procurement or managing sustainability programmes.

 

Elemental has positioned its laparoscopic portal product portfolio, including SI YelloPort Plus® and EliteTM trocars, to assist hospitals in their efforts to reduce plastic waste within the NHS-wide drive to deliver this important objective. The NHS commitment to the sustainability agenda comes from the highest level of the organisation. Simon Stevens, CEO of the NHS said:

 

"It's right that the NHS and our suppliers should join the national campaign to turn the tide on plastic waste. Doing so will be good for our environment, for patients and for taxpayers who fund our NHS."*

 

Disposal of plastic waste by hospitals is a huge cost, both as a direct cost and also the considerable cost to the environment as all clinical waste is incinerated. Kits sold by Elemental to the NHS can reduce plastic waste in a typical laparoscopic operation by more than 80%.**

 

Adam Power, Managing Director of Elemental Healthcare Ltd said: 

"The NHS has rightly been focussed on managing Covid-19 over the last three months, but we are seeing a considerable number of trusts re-engage on sustainability and plastic waste management as part of a long term strategy to reduce the NHS's carbon footprint, a key part of their future plan. Elemental Healthcare has a solution for operating theatre waste in the laparoscopic arena. What is more, over the past few months we have witnessed severe stress on the global supply chain and being a UK manufacturer is being recognised as providing a local solution for our partners in the NHS."

 

* At the time of launch of the NHS Long Term Plan to Reduce the Environmental impact of the Health Service, Oct 2019

** www.elementalhealthcare.co.uk

 

For further information please contact:

 

Surgical Innovations Group plc

www.sigroupplc.com

Nigel Rogers, Chairman

Tel: 0113 230 7597

David Marsh, CEO

N+1 Singer (Nominated Adviser & Broker)

Tel: 020 7496 3000

Aubrey Powell (Corporate Finance)

Rachel Hayes (Corporate Broking)

Walbrook PR (Financial PR & Investor Relations)

Tel: 020 7933 8780 or si@walbrookpr.com

Paul McManus / Lianne Cawthorne

Mob: 07980 541 893 / 07584 391 303

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAFZGGVGFVGGZZ
Date   Source Headline
18th Oct 20137:00 amRNSCFO to present at London Investor Show
17th Oct 20137:00 amRNSInternational Clinical Advisory Board Appointment
4th Oct 20137:00 amRNSAppointment to the Clinical Advisory Board
10th Sep 20137:00 amRNSInterim Results
16th Aug 20137:00 amRNSTrading update
19th Jun 20134:06 pmRNSResult of AGM
19th Jun 20132:00 pmRNSAGM Statement
10th Jun 20137:00 amRNSPilot hip arthroscopy test
3rd Jun 20137:00 amRNSAppointment to the Clinical Advisory Board
29th May 20137:00 amRNSNew US dealer
22nd May 20137:00 amRNSDevelopment agreement for Industrial application
8th May 20137:00 amRNSSnr Appointment of President US Sales & Operations
17th Apr 20137:00 amRNSAppointment to the Clinical Advisory Board
9th Apr 20137:00 amRNSPreliminary Results
18th Mar 20137:00 amRNSChange of Adviser
11th Mar 20137:00 amRNSUS appointment to ICAB
19th Feb 20137:00 amRNSTrading Update
23rd Jan 20137:00 amRNSPretzelFlex 3mm FDA approval
22nd Jan 20137:00 amRNSSecond order of 5mm PretzelFlex® shipped
17th Jan 20137:00 amRNSSI to benefit from £5.05m RGF Grant
10th Jan 20137:00 amRNSDirectors shareholding
18th Dec 20129:24 amRNSDirectors' dealings and issue of equity
18th Dec 20127:00 amRNSAppointments to the Clinical Advisory Board
29th Oct 20127:00 amRNSFirst PretzelFlex® orders shipped to CareFusion
11th Oct 20127:00 amRNSSuccessful exhibition at ISHA in the US
18th Sep 20127:00 amRNSHalf Yearly Report
4th Sep 20127:00 amRNSNotice of Results
30th Aug 20122:14 pmRNSHolding(s) in Company
26th Jun 20127:00 amRNSGrant of options
19th Jun 20123:33 pmRNSResult of AGM
19th Jun 20127:00 amRNSAGM Statement
18th Jun 20127:00 amRNSOEM distribution agreement with CareFusion
31st May 20127:00 amRNSUK distribution agreement
25th May 201211:58 amRNSDirectorate Change
22nd May 20127:00 amRNSPublication of Annual Report and Notice of AGM
1st May 20127:00 amRNSInvestor site visit
24th Apr 20127:00 amRNSFinal Results
20th Apr 20127:00 amRNSNotice of Results
15th Mar 20127:00 amRNSFDA 510(k) approval for reusable PretzelFlexT
23rd Feb 20124:54 pmRNSHolding(s) in Company
17th Feb 20124:36 pmRNSDirector/PDMR Shareholding
14th Feb 20125:49 pmRNSIssue of Equity
1st Feb 20127:00 amRNSRe: US contract and FDA approval
23rd Jan 20127:01 amRNSTrading Statement
2nd Dec 20117:00 amRNSInvestor Site Visit
3rd Nov 20117:00 amRNSIssue of Equity
1st Nov 20117:00 amRNSConfirmation of successful RGF bid
21st Sep 20114:49 pmRNSIssue of Equity
14th Sep 20117:00 amRNSHalf Yearly Report
1st Sep 20115:23 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.